P J Fletcher1, K M Korth, J W Chambers. 1. Department of Psychiatry, University of Toronto, Ontario, Canada. fletcher@psych.toronto.edu
Abstract
RATIONALE: Previously, we have shown that increasing 5-hydroxytryptamine (5-HT) activity attenuates responding for conditioned reward (CR), and the response potentiating effect of d-amphetamine on this behaviour. OBJECTIVES: The present experiments examined the effects of reducing 5-HT function on responding for CR. METHODS: In experiment 1, thirsty rats were trained to associate a CS+ with water delivery. The neurotoxin 5,7-DHT was then injected into the dorsal and median raphe nuclei. Subsequently, rats were treated with intraaccumbens d-amphetamine (1, 3, 10 micrograms) or saline and given access to two levers. One lever delivered the CS+ (now termed a CR), while the other was inactive. In experiment 2, the lesion was carried out prior to conditioning, and approach behaviour to the water magazine was measured during CS+ periods. Subsequently, rats were allowed to respond for the CS. In experiment 3, non-deprived rats learned to associate a CS+ with 10% sucrose; these animals also experienced a CS- which was not paired with sucrose. During a test phase responses on the two levers delivered either the CS+ or the CS-. RESULTS: 5,7-DHT substantially reduced 5-HT levels in striatum and hippocampus. In experiment 1, responding for the CR was enhanced by both d-amphetamine and 5-HT depletion in an additive fashion. In experiments 2 and 3, the discriminative control over behaviour exerted by the CS+ was not affected by 5-HT depletion. However, compared to control animals 5-HT-depleted rats showed higher levels of operant responding for the CR. CONCLUSIONS: Serotonin depletion selectively enhances responding for CR. Although 5-HT depletion did not potentiate the effects of d-amphetamine, it is suggested that CRs activate the mesolimbic dopamine system, and that removal of an inhibitory influence of 5-HT on the activity of this system results in increased responding for CR in 5,7-DHT-treated rats.
RATIONALE: Previously, we have shown that increasing 5-hydroxytryptamine (5-HT) activity attenuates responding for conditioned reward (CR), and the response potentiating effect of d-amphetamine on this behaviour. OBJECTIVES: The present experiments examined the effects of reducing 5-HT function on responding for CR. METHODS: In experiment 1, thirsty rats were trained to associate a CS+ with water delivery. The neurotoxin 5,7-DHT was then injected into the dorsal and median raphe nuclei. Subsequently, rats were treated with intraaccumbens d-amphetamine (1, 3, 10 micrograms) or saline and given access to two levers. One lever delivered the CS+ (now termed a CR), while the other was inactive. In experiment 2, the lesion was carried out prior to conditioning, and approach behaviour to the water magazine was measured during CS+ periods. Subsequently, rats were allowed to respond for the CS. In experiment 3, non-deprived rats learned to associate a CS+ with 10% sucrose; these animals also experienced a CS- which was not paired with sucrose. During a test phase responses on the two levers delivered either the CS+ or the CS-. RESULTS:5,7-DHT substantially reduced 5-HT levels in striatum and hippocampus. In experiment 1, responding for the CR was enhanced by both d-amphetamine and 5-HT depletion in an additive fashion. In experiments 2 and 3, the discriminative control over behaviour exerted by the CS+ was not affected by 5-HT depletion. However, compared to control animals 5-HT-depleted rats showed higher levels of operant responding for the CR. CONCLUSIONS:Serotonin depletion selectively enhances responding for CR. Although 5-HT depletion did not potentiate the effects of d-amphetamine, it is suggested that CRs activate the mesolimbic dopamine system, and that removal of an inhibitory influence of 5-HT on the activity of this system results in increased responding for CR in 5,7-DHT-treated rats.
Authors: Nadia Chaudhri; Anthony R Caggiula; Eric C Donny; Matthew I Palmatier; Xiu Liu; Alan F Sved Journal: Psychopharmacology (Berl) Date: 2005-10-21 Impact factor: 4.530
Authors: A G Romano; J L Quinn; R Liu; K D Dave; D Schwab; G Alexander; V J Aloyo; J A Harvey Journal: Psychopharmacology (Berl) Date: 2005-12-21 Impact factor: 4.530
Authors: Nadia Chaudhri; Anthony R Caggiula; Eric C Donny; Sheri Booth; Maysa Gharib; Laure Craven; Matthew I Palmatier; Xiu Liu; Alan F Sved Journal: Psychopharmacology (Berl) Date: 2006-09-22 Impact factor: 4.530
Authors: Paul J Fletcher; Fiona D Zeeb; Caleb J Browne; Guy A Higgins; Ashlie D Soko Journal: Psychopharmacology (Berl) Date: 2017-01-18 Impact factor: 4.530
Authors: Abigail G Schindler; Daniel I Messinger; Jeffrey S Smith; Haripriya Shankar; Richard M Gustin; Selena S Schattauer; Julia C Lemos; Nicholas W Chavkin; Catherine E Hagan; John F Neumaier; Charles Chavkin Journal: J Neurosci Date: 2012-12-05 Impact factor: 6.167